# Journey Medical Corporation (DERM)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/DERM/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 34.47M | $ -2.54M | $ 1.18M | $ 25.54M | $ 32.11M |
| 2025 | $ 63.34M | $ -11.70M | $ -12.74M | $ 25.40M | $ 31.85M |
| 2024 | $ 59.00M | $ -15.42M | $ -9.59M | $ 25.71M | $ 20.07M |
| 2023 | $ 85.61M | $ -4.17M | $ 259.5K | $ 17.73M | $ 20.35M |
| 2022 | $ 82.30M | $ -33.10M | $ -37.46M | $ 22.97M | $ 16.98M |
| 2021 | $ 75.04M | $ -52.29M | $ -4.02M | $ 9.05M | $ 42.04M |
| 2020 | $ 55.12M | $ 5.56M | $ 6.28M | $ 9.92M | $ 10.29M |
| 2019 | $ 104.07M | $ -181.24M | $ -176.81M | $ 295.57M | $ 14.48M |
| 2018 | $ 55.92M | $ -292.59M | $ -385.10M | $ 313.79M | $ -9.04M |
| 2017 | $ 6.12M | $ -408.53M | $ -140.43M | $ 279.39M | $ 149.65M |
| 2016 | $ 31.07M | $ -161.69M | $ -103.00M | $ 0 | $ 247.37M |
| 2015 | $ 20.50M | $ -110.08M | $ -68.30M | $ 0 | $ 185.48M |
| 2014 | $ 10.31M | $ -9.51M | $ -9.08M | $ 1.94M | $ 153.58M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.80 |
| Liabilities / Eq | 2.06 |
| Current Ratio | 1.59 |

## Other views

- [Metrics](https://sponda.capital/en/DERM.md)
- [Charts](https://sponda.capital/en/DERM/charts.md)
- [Compare](https://sponda.capital/en/DERM/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.